- Hikma Pharmaceuticals
- 22 August 2025 15:37:41
Source: Sharecast
Balan, who was appointed to the board of Hikma in 2022, purchased the shares at an average price of 1,820.70p each, for a total value of £63,724.50.
As of 1535 BST, Hikma shares were up 1.37% at 1,846p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Flutter Entertainment (di) (FLTR)
Director name: Jackson ,Peter
Amount purchased: 2,112 @ $292.42
Value: $509,269.46
Hikma Pharmaceuticals (HIK)
Director name: Balan,Laura Balan
Amount purchased: 3,500 @ 1,820.70p
Value: £63,724.50
Costain Group (COST)
Director name: Rock,Kate
Amount purchased: 10,000 @ 137.50p
Value: £13,750.10
Croda International (CRDA)
Director name: Ferguson,Jacqui
Amount purchased: 393 @ 2,524.27p
Value: £9,920.40
Anglo-eastern Plantations (AEP)
Director name: Chan,Marcus
Amount purchased: 500 @ 1,200.00p
Value: £6,000.00
Anglo-eastern Plantations (AEP)
Director name: Chan,Marcus
Amount purchased: 323 @ 1,230.00p
Value: £3,972.90
Anglo-eastern Plantations (AEP)
Director name: Chan,Marcus
Amount purchased: 177 @ 1,230.00p
Value: £2,177.10
Top Director Sells
Schroders Capital Global Innovation Trust (INOV)
Director name: Tufnell ,Jane
Amount sold: 300,903 @ 21.12p
Value: £63,550.66
Schroders Capital Global Innovation Trust (INOV)
Director name: Cohen,Stephen
Amount sold: 225,975 @ 21.12p
Value: £47,725.88
Frontier Developments (FDEV)
Director name: Braben ,David John
Amount sold: 5,000 @ 381.00p
Value: £19,050.00
Schroders Capital Global Innovation Trust (INOV)
Director name: Edwards,Tim
Amount sold: 45,031 @ 21.12p
Value: £9,510.54